Market capitalization | €825.50m |
Enterprise Value | €836.22m |
P/E (TTM) P/E ratio | 32.28 |
EV/FCF (TTM) EV/FCF | 34.22 |
EV/Sales (TTM) EV/Sales | 3.25 |
P/S ratio (TTM) P/S ratio | 3.21 |
P/B ratio (TTM) P/B ratio | 3.19 |
Dividend yield | 0.46% |
Last dividend (FY23) | €0.22 |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
6 Analysts have issued a NEXUS forecast:
6 Analysts have issued a NEXUS forecast:
Jun '24 |
+/-
%
|
||
Revenue | 257 257 |
16%
16%
|
|
Gross Profit | 53 53 |
12%
12%
|
|
EBITDA | 54 54 |
18%
18%
|
EBIT (Operating Income) EBIT | 35 35 |
19%
19%
|
Net Profit | 26 26 |
21%
21%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
NEXUS AG engages in the development and sale of software and hardware solutions. It operates its business through the Healthcare Software and Healthcare Services segments. The Healthcare Software segment provides software products on information systems for hospital and psychiatric, rehabilitation, and welfare institutions. The Healthcare Services offers information technology outsourcing services for institutions in the healthcare system. The company is headquartered in Donaueschingen, Germany.
Head office | Germany |
CEO | Ingo Behrendt |
Founded | 1999 |
Website | www.nexus-ag.de |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.